PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1605755
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1605755
Intraosseous Infusion Devices Market size was valued at USD 4,454 million in 2023, expanding at a CAGR of 6.7% from 2024 to 2032.
Intraosseous (IO) infusion devices are critical medical tools used to administer fluids and medications directly into the bone marrow, providing an alternative route for emergency drug delivery when intravenous access is challenging. These devices are typically employed in trauma, cardiac arrest, or shock scenarios where rapid intervention is necessary. They are designed for quick insertion, often in the tibia, humerus, or sternum, ensuring immediate access to the circulatory system. The growing demand for effective emergency care and advancements in IO technology have led to the development of more user-friendly and efficient devices.
Intraosseous Infusion Devices Market- Market Dynamics
Rise in the number of emergency care cases
Intraosseous Infusion Devices are critical tools used in emergency medicine to rapidly deliver fluids and medications when intravenous access is difficult or impossible. Drivers for growth in this market include increasing incidences of trauma, cardiac arrest, and emergency medical conditions that require immediate fluid administration. The rise in emergency care units, advancements in device technology, and the growing demand for quicker, effective treatments in pre-hospital settings are key factors propelling the market. Additionally, the growing focus on improving patient outcomes and reducing complications associated with traditional IV access is further boosting the adoption of intraosseous infusion devices.
Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.7% over the forecast period (2024-2032)
Based on Device Type segmentation, Manual IO Needles were predicted to show maximum market share in the year 2023
Based on End-Use segmentation, hospitals and clinics were the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Intraosseous Infusion Devices Market is segmented based on Device Type, End-Use, and region. Based on Device Type: Manual IO Needles, Battery Powered Driver and Impact Driven Devices. In 2023, the manual IO needles segment dominated the market owing to the rising incidence of tibia and fibula fractures, increased availability of manual IO needles, and heightened demand during emergency care procedures. Manual IO needles are especially favored for use in children due to their safety profile and ease of use once proper instruction is provided. Various types of manual IO needles are used depending on the surgical procedure, including butterfly, spinal, standard steel hypodermic, sternal, and trephine needles. Some of the most commonly used manual IO needles are the Cardinal Health Illinois/Jamshidi needle, Cook Critical Care Sur-Fast needle, and Cook Dieckman modified needle.
Based on End-Use: Hospitals and Clinics, Ambulatory Surgical Centers and Others. In 2024, the hospitals and clinics segment led the market owing to the availability of advanced infrastructure, increased investments in developing state-of-the-art healthcare facilities, and a rise in the number of skilled healthcare professionals. Additionally, hospitals and clinics are well-equipped with the latest technological treatment setups to manage various chronic conditions. These healthcare institutions also prioritize innovative treatment approaches and improved patient care, which helps reduce costs and fosters greater adoption of emergency services across different societal segments.
Intraosseous Infusion Devices Market- Geographical Insights
Intraosseous Infusion Devices (IOFDs) are used to rapidly administer fluids and medications into the bone marrow, typically in emergencies when IV access is difficult. The devices are designed to provide immediate vascular access, making them critical in trauma care, pediatric emergencies, and advanced cardiac life support. In terms of geographical insights, the North American market holds a dominant share due to the presence of advanced healthcare infrastructure and emergency response systems. Europe also shows significant demand, with increasing awareness about life-saving techniques. The Asia-Pacific region is expected to see growth, driven by rising healthcare needs in developing countries like India Japan and China.
The intraosseous infusion devices market is characterized by a competitive landscape with several key players striving to offer innovative solutions. Prominent companies include Teleflex Incorporated, known for its EZ-IO system, and Vidacare (now part of Teleflex), a major competitor with its MAXIO intraosseous device. Other notable players include ZOLL Medical Corporation, which offers the LifeFlow infusion system, and B. Braun Melsungen AG, which provides the Celsior device. The market is marked by growing demand due to the increasing need for emergency medical interventions, especially in trauma and critical care settings. Companies focus on enhancing device safety, ease of use, and reliability.
In June 2023, Teleflex Incorporated received 510(k) clearance from the U.S. FDA for its Arrow EZ-IO Needle with MR conditional labeling. This needle is a key component of the Arrow EZ-IO intraosseous vascular access system, featuring a diamond tip for efficient, accurate, and controlled insertion.
In January 2022, Safeguard Medical introduced the NIO+ Adult, a next-generation intraosseous infusion device. This compact and durable device is designed to withstand challenging environments, offering reliability and performance in harsh conditions.